Search - tctmd.com

Displaying 241 - 260 of 576

Sort: Relevancy | Date

Presentation THT 2023

The Current State of LVAD Therapy Today

Presenter: Jennifer Cowger

March 21, 2023

News Conference News THT 2023

Promising Preliminary Results for AccuCinch LV Restoration System in HFrEF

Todd Neale

March 21, 2023

Presentation THT 2023

Lessons Learned from Exercise Studies of LVAD Patients

Presenter: Donna Mancini

March 21, 2023

Presentation THT 2023

Aortic Stenosis With Acute LV Unloading With Septostomy

Presenter: Michael Cryer

March 21, 2023

Presentation THT 2023

MIRTH: Myocardial Intramural Remodeling by Transvenous Tether

Presenter: Adam Greenbaum

March 21, 2023

Presentation THT 2023

CardiacSuccess / V-Sling

Presenter: Horst Sievert

March 21, 2023

Presentation THT 2023

CardiacDimensions

Presenter: Samir Kapadia

March 21, 2023

Presentation THT 2023

Bioventrix

Presenter: Jerry Estep

March 21, 2023

Presentation THT 2023

Ancora

Presenter: Ulrich Jorde

March 21, 2023

Presentation THT 2023

Biological vs Physical Reverse Remodeling: Implications for Device-Based Therapies for HFrEF

Presenter: Michael Brener

March 21, 2023

Presentation THT 2023

Intravascular Monitoring: RA, PA, LA vs LV

Presenter: Michael Zile

March 21, 2023

Presentation THT 2023

Afterload pressure and LV function, but not circuit flow or direction, determine left atrial pressure during VA-ECMO

Presenter: Pankaj Jain

March 21, 2023

Presentation THT 2023

Effect of Supersaturated Oxygen (SSO2) on Left Ventricular Ejection Fraction (LVEF) in LAD STEMI Patients Post PCI in the Real World: Retrospective Comparison to Control Patients

Presenter: Tyler Bonkowski

March 21, 2023

News Conference News THT 2023

TEER or VAD/Transplant in the Advanced HF Patient With MR?

Shelley Wood

March 20, 2023

News Conference News THT 2023

PCI’s Role for Patients With HFrEF and Extensive CAD: Experts Debate

Todd Neale

March 20, 2023

Presentation THT 2023

What Are the Pros and Cons of the Win Ratio as the Primary Endpoint for Pivotal Heart Failure Trial

Presenter: Mandeep Mehra

March 20, 2023

Presentation THT 2023

What are the Strengths and Limitations of a Two-Phase (6-Month Intermediate Endpoints & 12-18 Month Mortality and Heart Failure Hospitalization) Trial Design

Presenter: William Abraham

March 20, 2023

Presentation THT 2023

FDA Introduction

Presenter: Changfu Wu

March 20, 2023

Presentation THT 2023

How Narrow or Broad Should Trial Enrollment Criteria Be to Achieve Clinically Interpretable Results? (STEMI vs NSTEMI; RV vs. LV vs. LV&RV Shock; AMI-CS vs Chronic HF-CS)

Presenter: Gregg Stone

March 20, 2023

Presentation THT 2023

Trans-Valvular LV Support: a Glimpse Into the Future

Presenter: Colin Hirst

March 20, 2023

Advertisement

The Current State of LVAD Therapy Today

Promising Preliminary Results for AccuCinch LV Restoration System in HFrEF

Lessons Learned from Exercise Studies of LVAD Patients

Aortic Stenosis With Acute LV Unloading With Septostomy

MIRTH: Myocardial Intramural Remodeling by Transvenous Tether

CardiacSuccess / V-Sling

CardiacDimensions

Bioventrix

Ancora

Biological vs Physical Reverse Remodeling: Implications for Device-Based Therapies for HFrEF

Intravascular Monitoring: RA, PA, LA vs LV

Afterload pressure and LV function, but not circuit flow or direction, determine left atrial pressure during VA-ECMO

Effect of Supersaturated Oxygen (SSO2) on Left Ventricular Ejection Fraction (LVEF) in LAD STEMI Patients Post PCI in the Real World: Retrospective Comparison to Control Patients

TEER or VAD/Transplant in the Advanced HF Patient With MR?

PCI’s Role for Patients With HFrEF and Extensive CAD: Experts Debate

What Are the Pros and Cons of the Win Ratio as the Primary Endpoint for Pivotal Heart Failure Trial

What are the Strengths and Limitations of a Two-Phase (6-Month Intermediate Endpoints & 12-18 Month Mortality and Heart Failure Hospitalization) Trial Design

FDA Introduction

How Narrow or Broad Should Trial Enrollment Criteria Be to Achieve Clinically Interpretable Results? (STEMI vs NSTEMI; RV vs. LV vs. LV&RV Shock; AMI-CS vs Chronic HF-CS)

Trans-Valvular LV Support: a Glimpse Into the Future

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content